Vitrafy Life Sciences Enters Partnership with US Blood Bank to Expand Cryopreservation Ecosystem for Red Blood Cells, Shares Jump 11%

MT Newswires Live

07/23

Vitrafy Life Sciences (ASX:VFY) entered a partnership with Hoxworth Blood Center in the US to expand the firm's cryopreservation ecosystem in response to the end-of-life of legacy red blood cell cryopreservation technology, according to a Thursday Australian bourse filing.

The firm said it was working to address red blood cell cryopreservation workflows resulting from the discontinuation of critical legacy technology starting in 2027. The agreement is not expected to generate revenue.

Under the partnership, Vitrafy and Hoxworth will both contribute resources and support in addressing this threat. Vitrafy will initially place one cryopreservation freezing and software package at Hoxworth during the first half of fiscal year 2027.

Its shares jumped 11% in recent trading on Thursday.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/2653792217"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2653792217\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2653792217?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-23 08:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2653792217","market":"sh","top_or_hot":-1,"title":"Vitrafy Life Sciences Enters Partnership with US Blood Bank to Expand Cryopreservation Ecosystem for Red Blood Cells, Shares Jump 11%","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/VFY.AU\">Vitrafy Life</a> Sciences (ASX:VFY) entered a partnership with Hoxworth Blood Center in the US to expand the firm's cryopreservation ecosystem in response to the end-of-life of legacy red blood cell cryopreservation technology, according to a Thursday Australian bourse filing.</p><p>The firm said it was working to address red blood cell cryopreservation workflows resulting from the discontinuation of critical legacy technology starting in 2027. The agreement is not expected to generate revenue.</p><p>Under the partnership, Vitrafy and Hoxworth will both contribute resources and support in addressing this threat. Vitrafy will initially place one cryopreservation freezing and software package at Hoxworth during the first half of fiscal year 2027.</p><p>Its shares jumped 11% in recent trading on Thursday.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vitrafy Life Sciences Enters Partnership with US Blood Bank to Expand Cryopreservation Ecosystem for Red Blood Cells, Shares Jump 11%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVitrafy Life Sciences Enters Partnership with US Blood Bank to Expand Cryopreservation Ecosystem for Red Blood Cells, Shares Jump 11%\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2026-07-23 08:53</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/VFY.AU\">Vitrafy Life</a> Sciences (ASX:VFY) entered a partnership with Hoxworth Blood Center in the US to expand the firm's cryopreservation ecosystem in response to the end-of-life of legacy red blood cell cryopreservation technology, according to a Thursday Australian bourse filing.</p><p>The firm said it was working to address red blood cell cryopreservation workflows resulting from the discontinuation of critical legacy technology starting in 2027. The agreement is not expected to generate revenue.</p><p>Under the partnership, Vitrafy and Hoxworth will both contribute resources and support in addressing this threat. Vitrafy will initially place one cryopreservation freezing and software package at Hoxworth during the first half of fiscal year 2027.</p><p>Its shares jumped 11% in recent trading on Thursday.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7048","symbol_name":"生命科學工具和服務","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2653792217","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2653792217","pubTimestamp":1784768019,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Vitrafy Life Sciences  entered a partnership with Hoxworth Blood Center in the US to expand the firm's cryopreservation ecosystem in response to the end-of-life of legacy red blood cell cryopreservation technology, according to a Thursday Australian bourse filing.The firm said it was working to address red blood cell cryopreservation workflows resulting from the discontinuation of critical legacy technology starting in 2027. The agreement is not expected to generate revenue.Under the partnership, Vitrafy and Hoxworth will both contribute resources and support in addressing this threat. Vitrafy will initially place one cryopreservation freezing and software package at Hoxworth during the first half of fiscal year 2027.Its shares jumped 11% in recent trading on Thursday.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7048":"生命科学工具和服务","VFY.AU":"Vitrafy Life Sciences Ltd"},"translate_title":"Vitrafy Life Sciences 与美国血库合作扩大红细胞冷冻保存生态系统，股价上涨 11%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VFY.AU":1},"content_text":"Vitrafy Life Sciences (ASX:VFY) entered a partnership with Hoxworth Blood Center in the US to expand the firm's cryopreservation ecosystem in response to the end-of-life of legacy red blood cell cryopreservation technology, according to a Thursday Australian bourse filing.The firm said it was working to address red blood cell cryopreservation workflows resulting from the discontinuation of critical legacy technology starting in 2027. The agreement is not expected to generate revenue.Under the partnership, Vitrafy and Hoxworth will both contribute resources and support in addressing this threat. Vitrafy will initially place one cryopreservation freezing and software package at Hoxworth during the first half of fiscal year 2027.Its shares jumped 11% in recent trading on Thursday.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}